Home › Compare › CUGCF vs ABBV
CUGCF yields 26.29% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 3
Combined, CUGCF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CUGCF + ABBV for your $10,000?
China Oriental Group Company Limited manufactures and sells iron and steel products for downstream steel manufacturers in the People's Republic of China. It operates through Iron and Steel, and Real Estate segments. The company offers H-section steel products for use in non-residential construction and infrastructure projects; strips and strip products; cold rolled sheets for use in manufacturing home electric appliances, hardware, pipes, etc.; galvanized sheets for production of civil-purpose sheets; billets for use as substrate in downstream steel products; and rebars for use in residential and non-residential projects. It also engages in the trade of steel, and iron ore and related products; leasing and financial leasing business; import and export of goods and technology; purchase and sale of ferrous metal and coke; development and sale of real estate properties; environmental protection engineering activities; non-metallic ore mining and trading; recycling of steel and waste materials; manufacture and sale of power transmission facilities; manufacturing of casting products; and research and development of recycling and energy-saving technology, as well as other recycling and construction engineering business. In addition, the company provides equipment maintenance, publication, construction project management, wholesale trade, asset management, logistics, commercial management, hotel and catering, cargo transit agency, and investment and management services; and architectural design, sale, and installation services, commercial consulting, technical advisory and software development, technology promotion, and new material technology and building engineering design services. Further, it offers factoring, capital market, and calligraphy and art training services; waste resources utilization services; produces and sells electricity; and sells metal materials and renewable resources. The company was incorporated in 2003 and is based in Wan Chai, Hong Kong.
Full CUGCF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.